Feb. 20, 2018 – In President Donald J. Trump’s FY 2019 Budget, drug pricing is one of the top priorities for the Department of Health and Human Services (HHS), according to HHS Secretary Alex Azar. “The President’s budget makes investments and reforms that are vital to making our health and human services programs work for […]
Read more
Jan. 8, 2018 – The New Jersey ban on “gifts” from the pharmaceutical industry, an administrative action finalized on Dec. 22, 2017, will go into effect on Jan. 15 of this year and will be “the first of its kind for any state” to link compliance with physician licensure and apply to physicians, not the […]
Read more July 31, 2017 — Guest commentary by Michael Parenti America’s opioid crisis is a major issue and the subject of ongoing debate. But before we can begin to tackle this problem, we need to take a look at the policy decisions that got us here. War has a way of embedding itself within the public consciousness. […]
Read more Commentary from Jack Angel, Coalition for Healthcare Communication Education Foundation Executive Director Oct. 25, 2016 – The Coalition for Healthcare Communication is dedicated to monitoring and resisting efforts by any organization, including our government, to restrict the free flow of truthful, scientific information. It is a fact that a great deal of scientific information flows […]
Read moreOct. 17, 2016 – In a recent guest commentary in PM360, Coalition for Healthcare Communication Executive Director John Kamp praised Pfizer for its opioid agreement with the City of Chicago and called on the pharmaceuticals industry to engage now in the fight to help stem the tide of opioid addiction. In the PM360 piece, “In […]
Read more
Aug. 19, 2016 – The Affordable Care Act (ACA) has resulted in increases in the use of prescription drugs and decreases in out-of-pocket spending, according to the RAND Corporation, which conducted a study of how expanded insurance coverage has affected populations that are at risk for high health spending. Health Affairs, which described the results […]
Read more
By Nick Colucci, Publicis Health CEO July 21, 2016 — I was moved by a recent op-ed in The New York Times written by former hedge fund trader and CEO of Everytable Sam Polk, which shed harsh light on how the persistence of “bro” talk continues to isolate and keep down women working in Wall […]
Read moreMay 17, 2016 — Healthcare policy improvements are underway in Washington, and industry advocacy makes a difference—that was the recurring message from speakers to an overflow audience of rising leaders in the healthcare communication industry as they met in Washington last week for an overview of healthcare policy in the evolving political landscape. “Much of the […]
Read moreMay 2, 2016 – In order to make reasonable coverage decisions about new medicines, payers need access to information from drug companies about those medicines prior to their FDA approval, a practice that currently is restricted under FDA policy, according to a recent blog post in The Catalyst, a Pharmaceutical Research and Manufacturers of America […]
Read moreFeb. 29, 2016 – When faced with criticism of drug pricing, industry members need to be able to defend drug companies, and arming themselves with the facts is a great start, according to Ilyssa Levins, president and founder of the Center for Communication Compliance, who recently posted an article in Pharmaceutical Compliance Monitor. The article, […]
Read more